J-Pharma
Developer of pharmaceutical drugs designed to target transporters aimed at cancer treatment. The company's drugs include anti-cancer drugs and positron emission tomography (PET) diagnostic agents agai...
Valuation
$203.1M
Latest known
Share Price
N/A
Total Raised
$65M
Last Round
N/A